Adult Pneumococcal Vaccinations Could Increase Under CDC Program
This article was originally published in The Pink Sheet Daily
Executive Summary
The Centers for Disease Control & Prevention is awarding a two-year contract to evaluate whether a proactive pharmacist pneumococcal vaccination program would increase adult use of the vaccine. Merck’s Pneumovax 23 is the only pneumococcal vaccine commercially available for adults.
You may also be interested in...
Flu Vaccine Manufacturing With Canine Kidney Cells To Be Discussed By Committee In November
FDA's vaccines advisory committee will discuss Madin-Darby canine kidney cells for flu vaccine manufacturing Nov. 16. Solvay submitted a drug master file for a canine cell-based influenza vaccine in June.
Flu Vaccine Manufacturing With Canine Kidney Cells To Be Discussed By Committee In November
FDA's vaccines advisory committee will discuss Madin-Darby canine kidney cells for flu vaccine manufacturing Nov. 16. Solvay submitted a drug master file for a canine cell-based influenza vaccine in June.
After A Year Of Prevnar Shortages, Wyeth Enters 2005 With Inventory On-Hand
Wyeth enters 2005 with "significant" Prevnar inventory, the company said during a quarterly earnings call Jan. 31